“Bullish on select Indian large-caps, including leading banks, capital goods majors, select automobiles, and pharmaceutical stocks. The current focus on the IPO market has depressed secondary market prices, creating buying opportunities for long-term investors, supported by the underlying strength of the US market and impressive corporate earnings. This is a strategic entry point for long-term growth.”